Send the following on WhatsApp
Continue to ChatThe relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study - https://avesis.ankara.edu.tr/yayin/aba155b8-6686-4b3a-81fb-c3b41fa0ab10/the-relationship-between-pan-immune-inflammation-value-and-survival-outcomes-in-patients-with-metastatic-renal-cell-carcinoma-treated-with-nivolumab-in-the-second-line-and-beyond-a-turkish-oncology-group-kidney-cancer-consortium-tkcc-study